Health Interests

The Pistoia Alliance Calls on the Life Sciences to Support Greater Collaboration to Overcome Technology Challenges

March 30, 2017

Machine learning, deep learning, and pre-competitive data analysis will deliver tangible benefits to patients  The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, is calling upon the industry to improve collaborative efforts to use patient data to its full effect. In a series of […]

New Guidelines Support Use of Cardiac Monitoring for Patients with Unexplained Fainting

March 27, 2017

American College of Cardiology, American Heart Association and Heart Rhythm Society Jointly Issue First-Ever Syncope Guidelines that Reinforce Benefits of Continuous Cardiac Monitoring DUBLIN – March 24, 2017 – Newly published guidelines from the American College of Cardiology (ACC), the American Heart Association (AHA), and the Heart Rhythm Society (HRS) recommend the use of cardiac […]

Ketamine For Severe Depression: ‘How Do You Not Offer This Drug To People?

March 23, 2017

Gerard Sanacora, a professor of psychiatry at Yale University, has treated hundreds of severely depressed patients with low doses of ketamine, an anesthetic and popular club drug that isn’t approved for depression. This sort of “off-label” prescribing is legal. But Sanacora says other doctors sometimes ask him, “How can you be offering this to patients […]

The Canadian Institute’s 3rd Annual Pharma Symposium

March 23, 2017

The Canadian Institute’s 3rd Annual Pharma Symposium The Road Ahead: From Clinical Trial to Market Access May 30-31, 2017 | One King West | Toronto Join us at The Canadian Institute’s 3rd Annual Pharma Symposium on May 30-31, 2017, where you’ll learn about the key issues facing the industry in today’s environment. Hear from a […]

New Approach Uses Ultrasound to Measure Fluid in the Lungs

March 22, 2017

FOR IMMEDIATE RELEASE A team of engineering and medical researchers has found a way to use ultrasound to monitor fluid levels in the lung, offering a noninvasive way to track progress in treating pulmonary edema – fluid in the lungs – which often occurs in patients with congestive heart failure. The approach, which has been […]

Award-Winning GoMo Health Concierge Care® Bedside Concierge™ Solution Launches in Sacred Heart Hospital’s Maternity and Women’s Center

March 22, 2017

Reduces Cost of Healthcare Delivery, Increases Patient Satisfaction and Provider Joy in Practice March 21, 2017 (Asbury Park, New Jersey) – Together with Sacred Heart Hospital, Pensacola, Florida, a member of the Ascension Health System, GoMo Health announces the launch of the award-winning Concierge Care® Inpatient Satisfaction Solution. The patient-centered solution offers mobile, in the […]

Sanofi Announces Results of First-of-Its-Kind Social Experiment Revealing Real-Life Impact of Symptoms on Allergy Sufferers in the U.S.

March 21, 2017

Bridgewater, N.J. – March 21, 2017 – Sanofi Consumer Healthcare – the makers of new Xyzal® Allergy 24HR, which is now available on retail shelves nationwide – revealed today the results of a social experiment in which 160 participants (80 allergy sufferers and 80 non-sufferers) wore a wearable device for 30 days to track their […]

Worldwide Introduces Latest Additions to Webinar Series, to Commemorate Multiple Sclerosis and Parkinson’s Awareness Months

March 21, 2017

MORRISVILLE, NC, MARCH 21, 2017 – Worldwide Clinical Trials (www.worldwide.com) has announced the latest additions to its free webinar series, with two webinars taking place in March and April to commemorate Multiple Sclerosis (MS) and Parkinson’s awareness months. The first of two informative sessions will address the emerging biosimilar market and its impact on MS […]

The Pistoia Alliance Tackles Laboratory Safety with the Launch of the Chemical Safety Library Service

March 20, 2017

Collaborative database of previously inaccessible hazardous chemical reactions improves safety for scientists carrying out experiments in the lab  The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, has today announced the launch of the Chemical Safety Library (CSL) Service, which allows hazardous reaction information to be […]

The Global Alzheimer’s Crisis: New Paradigms in Clinical Trials and Longitudinal Screening

March 20, 2017

There is scientific knowledge. And there is public perception. And often, the two collide. Nowhere is this reality more explicit than with the current state of Alzheimer’s disease research. Without a definitive cause or diagnosis – and no cure in sight – many adults see no reason to assess their risk, or determine their cognitive […]

Worldwide Clinical Trials Expert To Present At The American Academy Of Pain Medicine Annual Meeting

March 20, 2017

MORRISVILLE, NC, March 17, 2017 – Miroslav Backonja, M.D., Senior Medical Director at Worldwide Clinical Trials (www.worldwide.com), will be presenting two sessions at the American Academy of Pain Medicine (AAPM) Annual Meeting, being held March 16-18, 2017 in Orlando, Florida. Now in its 33rd year, AAPM brings together clinicians, researchers, and educators in pain medicine […]

Noventure and RFSU enter into agreement to commercialize Utipro® Plus across Nordic countries

March 16, 2017

Barcelona, March 13, 2017 – Noventure and Riksförbundet för sexuell upplysning (RFSU), the Swedish Association for Sexuality Education, announce today that they have entered into an agreement by which RFSU will distribute Noventure’s Utipro® Plus in the Nordic countries (Denmark, Finland, Iceland, Norway and Sweden). With this agreement, Utipro Plus is now available in 21 […]

UroToday.com, Leading Urology Reference Site, Launches a New Clinical Trials Portal

March 16, 2017

The first registry focused exclusively on genitourinary malignancies and trials actively enrolling patients Truckee, CA–Digital Science Press Inc., the global leader of the digital aggregation and delivery of urologic disease and treatment content through UroToday.com, announced today the launch of a Clinical Trials Portal on their website. This new portal is a streamlined access point […]

Bellerophon Therapeutics and Worldwide Clinical Trials Selected as Finalists in 2017 Care Awards

March 16, 2017

MORRISVILLE, NC, March 7, 2017 – Worldwide Clinical Trials (www.worldwide.com) and Bellerophon Therapeutics (www.bellerophon.com) have been selected as finalists in the 2017 Clinical Research & Excellence (CARE) Awards in the “Clinical Partnership of the Year” category. This category recognizes collaborations between organizations whose clinical trial activity has set a new benchmark in partnering activity. Partners […]

Leveraging FDA’s Expedited Programs: Now and in the Future

March 14, 2017

FDA is committed to advancing the development of therapies that treat serious conditions and rare diseases. As part of this commitment, FDA offers expedited programs for biopharmaceutical companies to reduce development and review timelines for new drugs and biologics that address unmet medical needs. In this webinar, Cardinal Health regulatory experts will examine FDA’s four […]

Norgine and Noventure enter into an agreement to commercialise Gelsectan® in Spain, Portugal and Andorra

March 7, 2017

Barcelona,  March 6, 2017 – Norgine B.V. and Noventure S.L. announce today that they have entered into an agreement by which Norgine will distribute Noventure’s Gelsectan® in Spain, Portugal and Andorra. Gelsectan is a Class IIa CE marked medical device used to restore the intestinal function in patients suffering from alterations due to irritable bowel […]

Sobi™ receives approval from the European Medicines Agency for higher capacity drug substance manufacturing for Elocta®

March 6, 2017

Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) has received approval from the European Medicines Agency (EMA) for the grouped type II 15 K Variation for Elocta® (efmoroctocog alfa). The variation involves several changes, including the approval of Elocta drug substance manufacturing in 15 000 litre scale bioreactors. Elocta is a recombinant extended half-life factor VIII […]

Early results show irregular heartbeat improves after stem cells treatment

March 6, 2017

Durham, NC – A new study published this month in STEM CELLS Translational Medicine indicates that treating heart patients with mesenchymal stem cells (MSCs) does not increase their risk of irregular heart beat (arrhythmia). In fact, the MSCs had the opposite effect and showed promise of improving the condition. “This could be an important breakthrough […]

FEEDBACK